Cours Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Actions
REKA
IL0010810096
Produits pharmaceutiques
CA 2022 | 292 M 76,8 M 70,15 M | CA 2023 | 322 M 84,49 M 77,17 M | Capitalisation | 169 M 44,32 M 40,47 M |
---|---|---|---|---|---|
Résultat net 2022 | -2 M -525 k -480 k | Résultat net 2023 | -6 M -1,58 M -1,44 M | VE / CA 2022 | 1,1 x |
Dette nette 2022 | 145 M 38,2 M 34,88 M | Dette nette 2023 | 166 M 43,72 M 39,93 M | VE / CA 2023 | 1,04 x |
PER 2022 |
-85,5
x | PER 2023 |
-24,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 17,36% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+17,35% | 71,39 Md | |
+2,39% | 25,1 Md | |
+5,38% | 8,59 Md | |
+6,69% | 8,19 Md | |
-20,96% | 7,91 Md | |
+0,49% | 4,54 Md | |
+17,12% | 4,31 Md | |
-3,38% | 3,93 Md | |
-2,61% | 3,86 Md |